Switching to tenofovir alafenamide in hbv: nationwide real life data of efficacy and safety from Turkey

Access

info:eu-repo/semantics/closedAccess

Date

2021

Author

Tabak, Fehmi
Yörük, Gülşen
Köksal, İftihar
Erdem, Hazal
Yıldız, Dilek
İnce, Nevin
Yamazhan, Tansu
Süme, Serkan
Batırel, Ayşe
Günal, Özgür
Yıldız, İlknur Esen
Sırmatel, Fatma
Koç, Meliha Merih
Çeken, Sabahat
Bozkurt, İlkay
Görenek, Levent
Şener, Alper
Köse, Şükran
Türker, Kamuran
İnan, Dilara
Karabay, Oğuz
Güner, Rahmet

Metadata

Show full item record

Citation

Tabak, F., Yörük, G., Köksal, İ., Erdem, H., Yıldız, D., İnce, N.,...Güner, R. (2021). Switching to tenofovir alafenamide in hbv: nationwide real life data of efficacy and safety from Turkey. Hepatology, 74, 497A-498A. https://www.webofscience.com/wos/woscc/full-record/WOS:000707188002220

Abstract

......

Source

Hepatology

Volume

74

URI

https://hdl.handle.net/11436/6785

Collections